VANRAFIA® (atrasentan) For US HCPs

Please see full Prescribing Information, including Boxed WARNING and Medication Guide at the "Learn more" link above or here: https://qr.qrhub.ly/VANPI. VANRAFIA is a Novartis Pharmaceuticals Corporation product and is not associated with any individual users on LinkedIn. This information is for US health care professionals only. To report suspected adverse reactions, contact Novartis Pharmaceuticals Corporation at 1-888-669-6682 or the FDA at 1-800-FDA-1088 or www.fda.gov/medwatch. This page is sponsored by Novartis Pharmaceuticals Corporation. 4/25 FA-11239039